share_log

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

SEC ·  Jan 31 12:16

Summary by Moomoo AI

Novartis AG has submitted its Annual Report 2024 and Novartis in Society - Integrated Report 2024 to the U.S. Securities and Exchange Commission on January 31, 2025. These comprehensive reports provide detailed insights into the company's financial performance, operational achievements, and sustainability initiatives for the fiscal year 2024.The filing, completed under Form 6-K as a foreign private issuer, demonstrates Novartis's commitment to maintaining transparent communication with investors and regulatory compliance with U.S. securities laws. The reports were officially signed by Paul Penepent, Head of Financial Reporting and Accounting.
Novartis AG has submitted its Annual Report 2024 and Novartis in Society - Integrated Report 2024 to the U.S. Securities and Exchange Commission on January 31, 2025. These comprehensive reports provide detailed insights into the company's financial performance, operational achievements, and sustainability initiatives for the fiscal year 2024.The filing, completed under Form 6-K as a foreign private issuer, demonstrates Novartis's commitment to maintaining transparent communication with investors and regulatory compliance with U.S. securities laws. The reports were officially signed by Paul Penepent, Head of Financial Reporting and Accounting.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 255

Recommended